About Reprogram Biosciences
Reprogram Biosciences is a private company based in San Carlos, California, incorporated in 2025 in Delaware. It has reported $6,000,000 raised in two offerings on Form D since May 2025. Its chief executive is Rustam Esanov.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | May 26, 2026 | $5,000,000fully sold | 2 | $2.5M | Simple Agreements for Future EquityRule 506(b) | Form D ↗ |
| May 9, 2025 | May 23, 2025 | $1,000,000fully sold | 3 | $333K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| Total, two offerings | $6,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Reprogram Biosciences's Form D filed May 26, 2026.
